Shire plc : Director/PDMR Shareholding
(Thomson Reuters ONE) -
Director/PDMR Shareholding
August 22, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG)
Notification of transaction by person discharging managerial responsibilities
+--+---------------------------------------------------------------------------+
|1.|Details of the person discharging managerial responsibilities ("PDMR") / |
| |person closely associated them ("PCA") |
+--+----------------------------------+----------------------------------------+
|a)|Name |Flemming Ornskov |
+--+----------------------------------+----------------------------------------+
|2.|Reason for the notification |
+--+----------------------------------+----------------------------------------+
|a)|Position / status |Chief Executive Officer - PDMR |
+--+----------------------------------+----------------------------------------+
|b)|Initial notification / amendment |Initial notification |
+--+----------------------------------+----------------------------------------+
|3.|Details of the issuer, emission allowance participant, auction platform, |
| |auctioneer or auction monitor |
+--+----------------------------------+----------------------------------------+
|a)|Name |Shire plc |
+--+----------------------------------+----------------------------------------+
|b)|LEI |54930005LQRLI2UXRQ59 |
+--+----------------------------------+----------------------------------------+
|4.|Details of the transaction(s): section to be repeated for (i) each type of |
| |instrument; (ii) each type of transaction; (iii) each date; and (iv) each |
| |place where transactions have been conducted |
+--+----------------------------------+ |
|a)|Description of the financial |Shire plc Ordinary Shares of 5 pence |
| |instrument, type of instrument |each ("Ordinary Shares") |
| | | |
| | | |
| | | |
| |Identification code |ISIN: JE00B2QKY057 |
+--+----------------------------------+----------------------------------------+
|b)|Nature of the transaction |Acquisition of Ordinary Shares |
+--+----------------------------------+--------+-------------------------------+
|c)|Price(s) and volume(s) |Price(s)| Volume(s) |
| | +--------+-------------------------------+
| | |£36.6493| 8,400 |
+--+----------------------------------+--------+-------------------------------+
|d)|Aggregated information |N/A (single transaction) |
| | | |
| |- Aggregated volume | |
| | | |
| |- Price | |
+--+----------------------------------+----------------------------------------+
|e)|Date of the transaction |August 22, 2017 |
+--+----------------------------------+----------------------------------------+
|f)|Place of the transaction |London Stock Exchange |
+--+----------------------------------+----------------------------------------+
Oliver Strawbridge
Senior Assistant Company Secretary
For further information please contact:
Investor Relations
Ian Karp ikarp(at)shire.com +1 781 482 9018
Robert Coates rcoates(at)shire.com +44 1256 894874
Media
Lisa Adler lisa.adler(at)shire.com +1 617 588 8607
Debbi Ford debbi.ford(at)shire.com +1 617 949 9083
NOTES TO EDITORS
About Shire
Shire is the leading global biotechnology company focused on serving people with
rare diseases. We strive to develop best-in-class products, many of which are
available in more than 100 countries, across core therapeutic areas including
Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders,
Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and
a growing franchise in Oncology.
Our employees come to work every day with a shared mission: to develop and
deliver breakthrough therapies for the hundreds of millions of people in the
world affected by rare diseases and other high-need conditions, and who lack
effective therapies to live their lives to the fullest.
www.shire.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Shire plc via GlobeNewswire
Datum: 22.08.2017 - 14:00 Uhr
Sprache: Deutsch
News-ID 557406
Anzahl Zeichen: 6106
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 230 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Shire plc : Director/PDMR Shareholding"
steht unter der journalistisch-redaktionellen Verantwortung von
Shire plc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
